{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:39:53Z","timestamp":1790177993002,"version":"4.1.0"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>The purpose of this article is to review the etiopathogenesis of dermatomyositis, including the predisposing factors, triggers, inflammatory cells, pathways and target antigens associated with dermatomyositis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>During the last few years, we have made considerable progress in unveiling the etiopathogenesis of dermatomyositis. In the first place, we have defined genes within the major histocompatibility complex locus as the greatest genetic risk factor for the disease. Second, we have demonstrated that certain environmental factors, as well as tumors, may trigger certain dermatomyositis subtypes. Moreover, we have established the importance of the interferon pathway in dermatomyositis pathogenesis compared with other myositis subtypes. But probably, the most remarkable advance has been the discovery of multiple autoantibodies that define groups of patients with characteristic clinical features, prognosis and response to treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Dermatomyositis cause and pathogenesis have proven to be a complex and fascinating task for the scientific community and the last decade has been full of new findings on how the disease starts and how it causes damage to different organ systems. However, we have still more questions than answers in this topic, answers that will be critical to understanding autoimmunity and finding effective therapies to dermatomyositis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000000540","type":"journal-article","created":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T21:20:21Z","timestamp":1535318421000},"page":"623-629","source":"Crossref","is-referenced-by-count":11,"title":["Dermatomyositis etiopathogenesis: a rebel soldier in the muscle"],"prefix":"10.1097","volume":"30","author":[{"given":"Iago","family":"Pinal-Fernandez","sequence":"first","affiliation":[{"name":"Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda"},{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Mammen","sequence":"additional","affiliation":[{"name":"Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda"},{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230901","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2009.05119.x","article-title":"Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis","volume":"1184","author":"Mammen","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"R2-20230901","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/art.1780280711","article-title":"The association between Mi-2 antibodies and dermatomyositis","volume":"28","author":"Targoff","year":"1985","journal-title":"Arthritis Rheum"},{"key":"R3-20230901","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/acr.23188","article-title":"Antinuclear matrix protein 2 autoantibodies and edema, muscle disease, and malignancy risk in dermatomyositis patients","volume":"69","author":"Albayda","year":"2017","journal-title":"Arthritis Care Res"},{"key":"R4-20230901","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.33379","article-title":"Usefulness of antip155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis","volume":"64","author":"Trallero-Araguas","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R5-20230901","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jim.2012.07.019","article-title":"Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort","volume":"384","author":"Tarricone","year":"2012","journal-title":"J Immunol Methods"},{"key":"R6-20230901","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kD polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R7-20230901","first-page":"1329","article-title":"Incidence of polymyositis\u2013dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963\u20131982","volume":"17","author":"Oddis","year":"1990","journal-title":"J Rheumatol"},{"key":"R8-20230901","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2474-13-103","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis","volume":"13","author":"Smoyer-Tomic","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"R9-20230901","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/rheumatology\/keq153","article-title":"Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis","volume":"49","author":"Hoshino","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R10-20230901","first-page":"891","article-title":"Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis\/dermatomyositis","volume":"32","author":"Ceribelli","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"R11-20230901","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1002\/art.34606","article-title":"Increased expression of vascular cell adhesion molecule 1 in muscle biopsy samples from juvenile dermatomyositis patients with short duration of untreated disease is regulated by miR-126","volume":"64","author":"Kim","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R12-20230901","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaut.2016.11.006","article-title":"Splicing factor proline\/glutamine-rich is a novel autoantigen of dermatomyositis and associated with antimelanoma differentiation-associated gene 5 antibody","volume":"77","author":"Hosono","year":"2017","journal-title":"J Autoimmun"},{"key":"R13-20230901","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.24702","article-title":"Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women","volume":"60","author":"Love","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R14-20230901","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2018.02.003","article-title":"The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis","author":"Schiffenbauer","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"R15-20230901","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/acr.22358","article-title":"Risk factors for juvenile dermatomyositis: exposure to tobacco and air pollutants during pregnancy","volume":"66","author":"Orione","year":"2014","journal-title":"Arthritis Care Res"},{"key":"R16-20230901","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/gene.2015.28","article-title":"Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes","volume":"16","author":"Miller","year":"2015","journal-title":"Genes Immun"},{"key":"R17-20230901","first-page":"2691","article-title":"Familial dermatomyositis","volume":"26","author":"Plamondon","year":"1999","journal-title":"J Rheumatol"},{"key":"R18-20230901","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2133.2001.04039.x","article-title":"Familial adult dermatomyositis","volume":"144","author":"Davies","year":"2001","journal-title":"Br J Dermatol"},{"key":"R19-20230901","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/1529-0131(199804)41:4<710::AID-ART19>3.0.CO;2-K","article-title":"Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy","volume":"41","author":"Rider","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R20-20230901","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/1529-0131(199803)41:3<400::AID-ART4>3.0.CO;2-5","article-title":"Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases","volume":"41","author":"Ginn","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R21-20230901","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1002\/art.24039","article-title":"Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis","volume":"58","author":"Mamyrova","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R22-20230901","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"R23-20230901","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/rheumatology\/kex413","article-title":"Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis","volume":"57","author":"Pinal-Fernandez","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"R24-20230901","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature04734","article-title":"Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses","volume":"441","author":"Kato","year":"2006","journal-title":"Nature"},{"key":"R25-20230901","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"R26-20230901","doi-asserted-by":"crossref","first-page":"e29161","DOI":"10.1371\/journal.pone.0029161","article-title":"Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases","volume":"7","author":"Wong","year":"2012","journal-title":"PLoS One"},{"key":"R27-20230901","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R28-20230901","doi-asserted-by":"crossref","first-page":"179180","DOI":"10.1155\/2014\/179180","article-title":"New onset of dermatomyositis\/polymyositis during anti-TNF-alpha therapies: a systematic literature review","volume":"2014","author":"Brunasso","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"R29-20230901","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF02826219","article-title":"Dermatomyositis after interferon alpha treatment","volume":"17","author":"Dietrich","year":"2000","journal-title":"Med Oncol"},{"key":"R30-20230901","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/jamadermatol.2014.2233","article-title":"Drug-associated dermatomyositis following ipilimumab therapy: a novel immune-mediated adverse event associated with cytotoxic T-lymphocyte antigen 4 blockade","volume":"151","author":"Sheik Ali","year":"2015","journal-title":"JAMA Dermatol"},{"key":"R31-20230901","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1046\/j.1365-2133.1999.03165.x","article-title":"A case of dermatomyositis that developed after delivery: the involvement of pregnancy in the induction of dermatomyositis","volume":"141","author":"Kanoh","year":"1999","journal-title":"Br J Dermatol"},{"key":"R32-20230901","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.semarthrit.2014.05.004","article-title":"Pregnancy in adult-onset idiopathic inflammatory myopathy\u2019: report from a cohort of myositis patients from a single center","volume":"44","author":"Pinal-Fernandez","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"R33-20230901","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/rheumatology\/ker430","article-title":"Maternal microchimerism in muscle biopsies from children with juvenile dermatomyositis","volume":"51","author":"Ye","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"R34-20230901","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(00)03499-1","article-title":"Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Childhood Myositis Heterogeneity Collaborative Group","volume":"356","author":"Artlett","year":"2000","journal-title":"Lancet"},{"key":"R35-20230901","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(05)71822-5","article-title":"Fetal microchimerism and inflammatory myopathies","volume":"357","author":"Selva-O\u2019Callaghan","year":"2001","journal-title":"Lancet"},{"key":"R36-20230901","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13075-015-0732-0","article-title":"Chimeric cells of maternal origin do not appear to be pathogenic in the juvenile idiopathic inflammatory myopathies or muscular dystrophy","volume":"17","author":"Artlett","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R37-20230901","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: an important tool to support diagnosis of myositis","volume":"280","author":"Betteridge","year":"2016","journal-title":"J Intern Med"},{"key":"R38-20230901","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.33403","article-title":"Myositis-specific anti155\/140 autoantibodies target transcription intermediary factor 1 family proteins","volume":"64","author":"Fujimoto","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R39-20230901","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/art.38093","article-title":"Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1gamma","volume":"65","author":"Fiorentino","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R40-20230901","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy","volume":"201","author":"Casciola-Rosen","year":"2005","journal-title":"J Exp Med"},{"key":"R41-20230901","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.24977","article-title":"Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle","volume":"60","author":"Mammen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R42-20230901","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","article-title":"Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity","volume":"76","author":"Pinal-Fernandez","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R43-20230901","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3899\/jrheum.141443","article-title":"The prevalence of individual histopathologic features varies according to autoantibody status in muscle biopsies from patients with dermatomyositis","volume":"42","author":"Pinal-Fernandez","year":"2015","journal-title":"J Rheumatol"},{"key":"R44-20230901","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13075-017-1383-0","article-title":"RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis","volume":"19","author":"Suarez-Calvet","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"R45-20230901","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/acr.22498","article-title":"Cutaneous ulceration in dermatomyositis: association with antimelanoma differentiation-associated gene 5 antibodies and interstitial lung disease","volume":"67","author":"Narang","year":"2015","journal-title":"Arthritis Care Res"},{"key":"R46-20230901","first-page":"45","article-title":"Dermatomyositis: immunopathologic study of skin lesions","volume":"15","author":"Dourmishev","year":"2006","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"R47-20230901","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198602063140601","article-title":"Microvascular deposition of complement membrane attack complex in dermatomyositis","volume":"314","author":"Kissel","year":"1986","journal-title":"N Engl J Med"},{"key":"R48-20230901","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archneur.1991.00530130034016","article-title":"The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis","volume":"48","author":"Kissel","year":"1991","journal-title":"Arch Neurol"},{"key":"R49-20230901","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.semarthrit.2017.06.001","article-title":"State of the art on nailfold capillaroscopy in dermatomyositis and polymyositis","volume":"47","author":"Bertolazzi","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"R50-20230901","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.410190203","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. III: Immunoelectron microscopy aspects of cell-mediated muscle fiber injury","volume":"19","author":"Arahata","year":"1986","journal-title":"Ann Neurol"},{"key":"R51-20230901","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.4049\/jimmunol.0803688","article-title":"T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells","volume":"183","author":"Fasth","year":"2009","journal-title":"J Immunol"},{"key":"R52-20230901","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.4049\/jimmunol.167.6.3521","article-title":"Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients","volume":"167","author":"Benveniste","year":"2001","journal-title":"J Immunol"},{"key":"R53-20230901","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/jaut.1994.1023","article-title":"The alpha beta T-cell receptor repertoire in inclusion body myositis: diverse patterns of gene expression by muscle-infiltrating lymphocytes","volume":"7","author":"O\u2019Hanlon","year":"1994","journal-title":"J Autoimmun"},{"key":"R54-20230901","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/art.24555","article-title":"Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy","volume":"60","author":"Niewold","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R55-20230901","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2353\/ajpath.2009.090196","article-title":"Overexpression of MHC class I heavy chain protein in young skeletal muscle leads to severe myositis: implications for juvenile myositis","volume":"175","author":"Li","year":"2009","journal-title":"Am J Pathol"},{"key":"R56-20230901","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","article-title":"Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies","volume":"97","author":"Nagaraju","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R57-20230901","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1212\/WNL.0000000000003568","article-title":"Sarcoplasmic MxA expression: a valuable marker of dermatomyositis","volume":"88","author":"Uruha","year":"2017","journal-title":"Neurology"},{"key":"R58-20230901","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/art.1780371206","article-title":"Elevated serum levels of interleukin-1 receptor antagonist in polymyositis\/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response","volume":"37","author":"Gabay","year":"1994","journal-title":"Arthritis Rheum"},{"key":"R59-20230901","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/rheumatology\/keu258","article-title":"Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease","volume":"53","author":"Gono","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"R60-20230901","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/intimm\/dxf062","article-title":"Increased IL-15 production of muscle cells in polymyositis and dermatomyositis","volume":"14","author":"Sugiura","year":"2002","journal-title":"Int Immunol"},{"key":"R61-20230901","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/03009742.2010.517215","article-title":"Interleukin-17 and interleukin-23 in patients with polymyositis and dermatomyositis","volume":"40","author":"Shen","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"R62-20230901","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/rheumatology\/keq196","article-title":"Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R63-20230901","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10067-009-1316-7","article-title":"Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis","volume":"29","author":"Kim","year":"2010","journal-title":"Clin Rheumatol"},{"key":"R64-20230901","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00005072-199705000-00003","article-title":"Transforming growth factor-beta 1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infiltrate","volume":"56","author":"Confalonieri","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"R65-20230901","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jneuroim.2012.04.006","article-title":"The expression of BAFF in the muscles of patients with dermatomyositis","volume":"249","author":"Baek","year":"2012","journal-title":"J Neuroimmunol"},{"key":"R66-20230901","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1172\/JCI118749","article-title":"Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis","volume":"97","author":"Goebels","year":"1996","journal-title":"J Clin Invest"},{"key":"R67-20230901","first-page":"801","article-title":"Immunohistochemical analysis of adhesion molecule expression on muscle biopsy specimens from patients with juvenile dermatomyositis","volume":"31","author":"Sallum","year":"2004","journal-title":"J Rheumatol"},{"key":"R68-20230901","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-2230.2009.03297.x","article-title":"Identification of granzyme B-expressing CD-8-positive T cells in lymphocytic inflammatory infiltrate in cutaneous lupus erythematosus and in dermatomyositis","volume":"34","author":"Grassi","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"R69-20230901","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1365-2133.2000.03668.x","article-title":"Increased serum levels of soluble vascular cell adhesion molecule-1 and soluble E-selectin in patients with polymyositis\/dermatomyositis","volume":"143","author":"Kubo","year":"2000","journal-title":"Br J Dermatol"},{"key":"R70-20230901","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0022-510X(89)90228-1","article-title":"Early ultrastructural alterations in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle","volume":"94","author":"De Visser","year":"1989","journal-title":"J Neurol Sci"},{"key":"R71-20230901","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0022-510X(74)90148-8","article-title":"Experimental ischemic myopathy","volume":"23","author":"Karpati","year":"1974","journal-title":"J Neurol Sci"},{"key":"R72-20230901","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archneur.1970.00480220079011","article-title":"Experimental myopathy after microarterial embolization; comparison with childhood x-linked pseudohypertrophic muscular dystrophy","volume":"22","author":"Hathaway","year":"1970","journal-title":"Arch Neurol"},{"key":"R73-20230901","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1093\/brain\/awv192","article-title":"Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis","volume":"138","author":"Mescam-Mancini","year":"2015","journal-title":"Brain"},{"key":"R74-20230901","doi-asserted-by":"crossref","first-page":"8595","DOI":"10.1038\/s41598-017-09309-8","article-title":"Hypoxia triggers IFN-I production in muscle: implications in dermatomyositis","volume":"7","author":"De Luna","year":"2017","journal-title":"Sci Rep"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201811000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T21:17:33Z","timestamp":1693516653000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201811000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000540","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}